|
⚲
|
| Keyboard |
| Yerxa Benjamin R
✚
|
|
|---|---|
| CIK # | 0001145910 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001145910] | |
| 4 | [0001145910] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Rexahn Pharmaceuticals Inc | |
| Yerxa Benjamin R | |
| Clearside Biomedical Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2026-01-22 | Grant | 400,000 | $0.00 | |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2025-10-22 | Tax withheld | 23,795 | $1.95 | 46,400 |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2024-11-21 | Buy | 10,000 | $0.98 | 9,800 |
|
Rexahn Pharmaceuticals Inc IRD
Common Stock
|
2024-11-07 | Grant | 332,800 | $0.00 | |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2024-06-20 | Grant | 45,000 | $0.00 | |
|
Clearside Biomedical Inc CLSD
Common Stock
|
2024-05-15 | Buy | 7,813 | $1.31 | 10,235 |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2023-06-22 | Grant | 30,000 | $0.00 | |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2022-06-22 | Grant | 30,000 | $0.00 | |
|
Clearside Biomedical Inc CLSD
Stock Option (right to buy) · derivative
|
2022-03-02 | Grant | 30,000 | $0.00 |